26
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Fas is Expressed in Murine Pancreatic Islet Cells and an Insulinoma Cell Line but Does Not Mediate Their Apoptosis in vitro

, , , &
Pages 189-199 | Received 16 Jul 1998, Published online: 07 Jul 2009

References

  • Christianson S. W., Shultz L. D., Leiter E. H. Adoptive transfer of diabetes into immunodeficient NOD-scid scid mice. Diabetes 1993; 42: 44–55
  • Haskins K., MeDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990; 249: 1433–6
  • Bradley B. J., Haskins K., La Rosa E. G., Laff'erty K. L. CDS T cells are not required for islet destruction induced bv a CD4+ islet-specific T-cell clone. Diabetes 1992; 41: 1603–8
  • Wang B., Gonzalez A., Benoist C., Mathis D. The role of CD8+ cells in the initiation of insulin-dependent diabetes mellitus. Eur. J Immunol. 1996; 26: 1762–9
  • Signore A., Cooke A., Pozzilli P., Butcher G., Simpson E., Beverley P. C. Class II and 1L-2 receptor positive cells in the pancreas of NOD mice. Diabetologia 1987; 30: 902–5
  • Hanafusa T., Fuhino-Kunihara E L, Miyazaki A., Yamada K., Nakajima H., Miyagawa J., Kono K., Tarui S. Expression of class II MHC antigens on pancreatic β lls in the NOD mouse. Diabelologia 1987; 30: 104–8
  • Wang Y., Pontcsilli O., Gill R. D., La Rosa E. G., Lafferty K. I. The role ofCD4f and CD8 f T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Null. Acad. Sci. USA 1991; 88: 527–31
  • Kagi D., Vignaux I., Ledermann B., Burki K., Depraetere V., Nagata S., Hcngartner H., Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528–30
  • Mogil R. L, Radvanyi L., Gonzalez-Ouinlial R., Miller R., Mills G., Theofiiopoulos A. N., Green D. R. Eas. (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Inl. Immunol. 1995; 7: 1451–8
  • Parijs L. V., Ibraghimov A., Abbas A. K. The role of costimulalion and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996; 4: 321–8
  • Ju S.-T., Cui E E, Panka D. J., Ettinger R., A. M.-R. Participation of target Eas protein in apoptosis pathway induced by CD44 Th I and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1994; 9E: 4185–9
  • Stalder T., Hahn S., Erb P. Eas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994; 152: 1127–33
  • Wang R., Rogers A. M., Ratliff T. L., Russell J. H. CD95-dependent bystander lysis caused by CD44- T helper 1 effectors. J. Immunol. 1996; 157: 2961–8
  • Zamvil S. S., Nelson P. A., Mitchell D. J., Knobler R. L., Fritz R. B., Steinman L. Encephalitogenic T cell clones specific for myelin basic protein. An usual bias in antigen recognition. J. Exp. Med. 1985; 162: 2107–24
  • Zamvil S., Nelson P., Protter J., Mitchell D., Knobler R., Eril7 R., Steinman L. T-eell. clones specific for myelin basic protein induce chronic relapsing paralysis and dcmyelination. Nature 1985; 317: 355–8
  • Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/F'as) receptor/Hgand system in multiple scleosis brain. J Exp. Med. 1996; 184: 1513–8
  • Chervonsky A. V., Wang Y., Wong E. S., Visimin L, Elavell R. A., Jancway C. A., Matis L. A. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17–24
  • Itoh N., lmagawa A., Hanafusa T., Waguri M., Yamamoto K., Ivvahashi H., Moriwaki M., Nakajima H., Miyagawa J., Namba M., Makino S., Nagata S., Kono M., Matsuzawa Y. Requirement of Eas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 1997; 186: 613–8
  • Yagi N., Yokono K., Amano K., Nagata M., Tsukamoto K., Hasegawa Y., Yoneda R., Okamoto N., Moriyama H., Miki M., Tominaga Y., Miyazaki I.-I., Yagita H., Oktimura K., Mizoguchi A., Miki A., Ide C, Maeda S., Kasuga M. Expression of intercellular adhesion molecule 1 on pancreatic. β-cells accelerates. (-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 1995; 44: 744–52
  • Matsumoto K., Fukunaga K., Miyazaki I.-I., Shichiri M., Miyamoto E. Ca2+/calmodulin-dependent protein kinase II and synasin 1 -like protein in mouse insulinoma MIN6 cells. Endocrinology 1995; 136: 3784–93
  • Kayagaki N., Yamaguchi N., Nagao F., Matsuo S., Maeda I, Okumura E. K., Yagita H. Polymorphism of murine Eas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 1997; 94: 3914–9
  • Lee M.-S., Wogcnsen L., Shizuru J., Oldstone M B.A., Sarvetnick N. Pancreatic islet production of murine interleukin 10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 1994; 93: 1332–8
  • Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A. Eas ligand-induced apoptosis as a mechanism of immune previlege. Science 1995; 270: 1189–92
  • Bellgrau D., Gold D., Seiawry H., Moore J., Franzusoff A., Duke R. C. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 6.30–2
  • Giordano C., Stassi G., De Maria R., Todaro M., Richiusa P., Papoff G., Ruberti C i., Bagnasco M., Testi R., Gallulzo A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960–3
  • Ogasawara J., Suda T., Nagata S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp. Med. 1995; 181: 485–91
  • Ni R., Tomita Y., Ichihara A., Ishimura K., Ogasawara J., Nagata S. Fas-mediated apoptosis in primary cultured mouse hepatocyte. Exp. Cell Res. 1994; 215: 332–7
  • Elstein K. H., Zucker R. M. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptoticsubpopulation. Exp. Cell. Res. 1994; 211: 322–31
  • Santamaria P., Utsugi T., Park B.-J., Averill N., Kawazu S., Yoon J.-W. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor o-chain CDR3 sequences. J Immunol 1995; 154: 2494–503
  • Alderson M. R., Tough T. W., Davis-Smith T., Braddy S., Ealk B., Schooley K. A., Goodwin R. G., Smith C. A., Ramsdell E., Lynch D. H. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp. Med. 1995; 181: 71–7
  • Yang Y., Merccp M., Ware C. E., Ashwell J. D. las and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Eas ligand expression by retinoic acid and glucocorticoid. J of Exp. Med. 1995; 181: 1673–82
  • Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. Expression of Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806–13
  • Watanabe-Fukunaga R., Brynnan C. I., Itoh N., Yonehara S., Copeland N. G., Jenkins N. A., Nagata S. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 1992; 148: 1274–9
  • Yamada K., Takane-Gyotoku N., Yuan X., Ichikawa F., Nonaka K. Mouse islet cell lysis mediated by interieukin-1-induced Fas. Diahetologia 1996; 39: 1306–12
  • Shima Y., Nishimoto N., Ogata A., Fujii Y., Yoshizaki K., Kishimoto T. Myeloma. cells express Fas antigen, APO-I (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 1995; 85: 757–64
  • Itoh N., Tsiijimoto Y., Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 1993; 151: 621–7
  • Boise L. H., Thompson C. B. Hicrachial control of lymphocyte survival. Science 1996; 274: 67–8
  • O'Brien B. A., Harmon B. V., Cameron D. P., Allan D. J. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997; 46: 750–7
  • Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806–9
  • Bianeonc L., Dc Martino A., Orlandi V., Conaldi P. G., Toniolo A., Camussi G. Development of inflammatory angiogenesis by local stimulation with Fas /'/; vivo. J. Exp. Med. 1997; 186: 147–52

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.